Author's summary
The Korean Society of Cardiology has recently published the Korea Heart Disease Fact Sheet 2020 to provide overview of the cardiovascular disease (CVD) burden and its temporal changes. CVD mortality, hospitalization, and risk factor distributions were analyzed from nationwide databases. Over the last decade, CVD mortality and hospitalization have increased, while their age-standardized rates have declined. In addition, a considerable proportion of adults had multiple risk factors, which markedly increased with older age. Thus, concerted efforts should be continued to address the rising burden of CVD in Korea.
Keywords: Circulatory system, Heart diseases, Hospitalization, Mortality, Risk factors
Abstract
Background and Objectives
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. To provide an overview of the temporal trends in the burden of CVD, the Korean Society of Cardiology has published the Korea Heart Disease Fact Sheet in 2020.
Methods
We analyzed anonymized data of the Causes of Death Statistics, National Health Insurance Claims Database, and Korea National Health and Nutrition Examination Survey to assess mortality, hospitalizations, and risk factors for CVD.
Results
The CVD mortality decreased until 2010, then steadily increased up to 123 per 100,000 persons in 2018. Since 2002, the number and rate of CVD hospitalization have continued to grow. In 2018, approximately 12.1 million Korean adults had hypertension, 4.3 million had diabetes, 8.7 million had hypercholesterolemia, 14.9 million had obesity, and 8.8 million were currently smoking. The number of risk factors increased markedly with older age; 58.4% of adults age ≥70 years had ≥2 risk factors.
Conclusions
CVD mortality and hospitalization have gradually increased in the last decade, and a substantially high proportion of adults were carrying more than 1 cardiovascular risk factor in 2018. With the rapid population aging, a continued increase in CVD appears inevitable in Korea. Concerted and sustained approaches are essential to achieve early prevention and reduce the burden of CVD.
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for nearly one-third of all deaths.1),2) The same holds true for Korea, where heart disease has been the leading cause of death for nearly a decade.3) Since a significant portion of CVD is preventable, the importance of adequate prevention strategies has long been emphasized.4) To implement such strategies and subsequently reduce the burden of CVD, magnitude and temporal trends in mortality, morbidity, and risk factors of CVD need to be clearly identified. In Korea, the Statistics Korea (formerly the National Statistical Office) has annually released anonymized data on the causes of death since 1983 based on the death registry.3) The temporal trend in CVD mortality has been repeatedly reported with this data.5),6),7) On the contrary, nationally representative data on CVD morbidity are extremely limited, making it difficult to accurately assess the incidence and prevalence of CVD in Korea. Although there have been several studies estimating the burden of CVD using the National Health Insurance claims data that cover the entire Korean population,8),9),10),11),12),13) most of the studies were confined to specific disease categories, such as myocardial infarction (MI),8),9) cerebrovascular diseases,10),11) or heart failure (HF).12),13) Moreover, substantial heterogeneity in study methods makes it inappropriate to compare their results directly. Regarding cardiovascular risk factors, fact sheets describing the prevalence and management status of hypertension, diabetes, dyslipidemia, obesity, and metabolic syndrome have been published by affiliated academic societies of Korea.14),15),16),17),18) Nonetheless, comprehensive data summarizing the overall status of CVD in Korea has not been reported yet. Thus, we analyzed the temporal trends in CVD mortality, hospitalization, and risk factors based on nationally representative datasets on behalf of the Korean Society of Cardiology.
METHODS
Ethical statement
The present study complied with the Declaration of Helsinki and was approved by the Institutional Review Board of Yonsei University Health System, Seoul, Korea (No. 4-2020-0207). Informed consent was waived since this is a retrospective study of de-identified administrative data.
Classification of circulatory system diseases
All diseases of circulatory system were categorized into heart diseases, cerebrovascular diseases, and other circulatory diseases. Heart diseases were further classified into subcategories, including ischemic heart diseases (IHD), HF, and hypertension. MI was considered a subcomponent of IHD. The overall classification scheme and corresponding International Classification of Diseases-10 (ICD-10) codes are presented in Table 1.
Table 1. Classification of cardiovascular diseases.
| Disease category | ICD codes (10th revision) | |||
|---|---|---|---|---|
| All diseases of circulatory system | I00–I99 | |||
| Heart diseases | I00–I13, I20–I28, I30–I51 | |||
| Ischemic heart diseases | I20–I25 | |||
| Myocardial infarction | I21–I23 | |||
| Heart failure | I50 | |||
| Hypertension | I10–I13 | |||
| Cerebrovascular diseases | I60–I69 | |||
| Other circulatory diseases | I15, I52, I70–I99 | |||
ICD, International Classification of Diseases.
Assessment of cardiovascular disease mortality
The Korean Statistical Information Service-Microdata Integrated Service (KOSIS-MDIS) covers the entire resident-registered population and a portion of unidentified individuals in Korea. Based on mortality data provided by the KOSIS-MDIS, we calculated the annual CVD mortality rate between 1983 and 2018. In addition, age-standardization was performed by the direct method to adjust for changing population structures over time. Specifically, the standardization was performed with the population structure of the resident-registered population in 2018 as a reference, separately by sex.
Assessment of cardiovascular disease hospitalizations
Using National Health Insurance Big Data (NHIBD), we evaluated the magnitude and temporal trends of CVD hospitalizations between 2002 and 2018 among adults aged ≥20 years covered by the National Health Insurance.19) For each year, we estimated the number of people hospitalized for CVDs. Then, CVD hospitalization rate was defined as the number of people hospitalized for CVD over the total number of insured people in that year. Age-standardized hospitalization rates were calculated with the direct method based on the population structure of insured people in 2018. As a diagnosis code for hospitalization can be recorded either as a primary diagnosis or other diagnoses, numbers of adults hospitalized for CVDs were estimated separately based on (1) primary diagnosis and (2) all diagnoses during hospitalization.
Assessment of cardiovascular risk factors
Using the Korea National Health and Nutrition Examination Survey (KNHANES) data, we assessed the current CVD risk factor distribution among adults aged ≥20 years who completed the KNHANES in 2018. The five major CVD risk factors included hypertension, diabetes, hypercholesterolemia, obesity, and current smoking (Table 2). We estimated the number of adults with each risk factor based on the weighted prevalence calculated from the KNHANES data. The number of adults with dyslipidemia was also assessed. Subsequently, we categorized the participants by the number of major risk factors (0, 1, 2, and ≥3) and examined its distribution by age and sex. All analyses of the KNHANES data accounted for the complex survey design adopted in the KNHANES to generate nationally representative estimates for the noninstitutionalized Korean population.20)
Table 2. Definition of cardiovascular risk factors.
| Risk factor | Definition |
|---|---|
| Hypertension | (1) Systolic blood pressure ≥140 mmHg or |
| (2) Diastolic blood pressure ≥90 mmHg or | |
| (3) Taking antihypertensive agent | |
| Diabetes | (1) Fasting blood glucose ≥126 mg/dL or |
| (2) Taking oral hypoglycemic agent or under insulin therapy | |
| Hypercholesterolemia | (1) Total cholesterol ≥240 mg/dL or |
| (2) Taking lipid-lowering agent | |
| Obesity | Body mass index ≥25 kg/m2 |
| Current smoking | Has smoked ≥100 cigarettes in lifetime and is currently smoking |
Additionally, dyslipidemia was defined as (1) low-density lipoprotein cholesterol ≥160 mg/dL or (2) triglyceride ≥200 mg/dL or (3) high-density lipoprotein cholesterol <40 mg/dL or (4) taking lipid-lowering agent.
Statistical analysis
All statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) and R version 4.0.3 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Cardiovascular disease mortality
The mortality rate due to all diseases of circulatory system declined until 2010 and steadily increased afterward up to 123 per 100,000 persons in 2018 (Figure 1, Supplementary Table 1). Such shift is most likely due to population aging, as the age-standardized mortality rate has continued to decrease even after 2010 (Supplementary Figure 1). There was also a transient peak in circulatory system diseases mortality around 1994 when the ICD system was revised from 9th to 10th revision. In the last decade, mortality due to heart diseases, IHD, HF, and hypertension have increased. During the same period, mortality due to MI has been stagnant, whereas cerebrovascular diseases mortality has declined (Figure 1, Supplementary Table 1). Further details on the 36-year trend of mortality from diseases of circulatory system in Korea are presented elsewhere.21)
Figure 1. Changes in cardiovascular disease mortality rate, 1983–2018.
Hospitalization for cardiovascular diseases
Since 2002, the numbers of adults hospitalized for all diseases of circulatory system, heart diseases, and cerebrovascular diseases have consistently escalated based on both primary and all hospital diagnoses (Figure 2). Between 2002 and 2018, the number of people hospitalized increased 3.7 fold (from 169 thousand to 630 thousand) for all circulatory system diseases, 3.7 fold (from 91 thousand to 333 thousand) for heart diseases, and 3.5 fold (from 65 thousand to 227 thousand) for cerebrovascular diseases based on primary diagnosis (Figure 2A). Based on all hospital diagnoses, the number increased 4.5 fold (from 444 thousand to 1,994 thousand) for all circulatory system diseases, 4.1 fold (from 391 thousand to 1,600 thousand) for heart diseases, and 4.5 fold (from 105 thousand to 474 thousand) for cerebrovascular diseases (Figure 2B).
Figure 2. Changes in the number of people hospitalized for cardiovascular disease, 2002–2018. Estimated based on (A) primary diagnosis and (B) all diagnoses during hospitalization.
The hospitalization rate for all circulatory system diseases based on primary diagnosis also increased to 1,455 per 100,000 persons in 2018 (Figure 3A, Supplementary Table 2). The hospitalization rates for heart diseases and those for cerebrovascular diseases increased until 2016; after that, the heart diseases hospitalization rate continued to grow, while the cerebrovascular diseases hospitalization rate started to decline. Among heart diseases, the hospitalization rate due to HF exhibited the greatest increase (3.5-fold), followed by hypertension (2.7-fold), IHD (2.6-fold), and MI (1.9-fold) (Figure 3A, Supplementary Table 2).
Figure 3. Changes in cardiovascular disease hospitalization rate, 2002–2018. (A) Crude rate. (B) Age-standardized rate. Age-standardization was performed by direct method with the population structure of insured people in 2018 as a reference.
Again, such trends could be attributed in part to population aging in Korea. The age-standardized hospitalization rates for all circulatory system diseases and their components had continually risen until 2009. (Figure 3B, Supplementary Table 3) Since then, the hospitalization rates for all circulatory system diseases, heart diseases, and cerebrovascular diseases have slowly declined. At the same time, the hospitalization rate for hypertension also decreased steadily, while the rate for HF declined until 2015 and increased thereafter. The hospitalization rate for IHD remained stagnant until 2012 then fluctuated. On the contrary, the hospitalization rate for MI decreased until 2011 then increased afterward (Figure 3B, Supplementary Table 3).
Cardiovascular risk factors
In 2018, approximately 12.1 million adults had hypertension, 4.3 million had diabetes, 8.7 million had hypercholesterolemia, 14.9 million were obese, and 8.8 million were currently smoking (Figure 4). The proportion of people with ≥2 risk factors rapidly increased with older age, ranging from 14.7% in the age group of 20-29 years to 58.4% in the age group of ≥70 years. Moreover, 27.8% of people aged ≥70 years had 3 or more cardiovascular risk factors (Figure 5A). This age-related trend was apparent in both sexes. Whereas men had a greater number of risk factors until age 70, the number surpassed among women at age >70 years (Figure 5B and C).
Figure 4. Number of Korean adults with each cardiovascular risk factor, 2018.
Figure 5. Number of cardiovascular risk factors by sex and age, 2018. (A) In all sex. (B) In men. (C) In women.
DISCUSSION
CVD mortality has increased during the last decade in Korea. Such increment was mainly driven by heart diseases, while mortality due to cerebrovascular diseases has declined over the past 2 decades. Hospitalization for CVD has also continually increased, with every CVD category showing a 2-3-fold increase between 2002 and 2018. Age-standardization revealed that the aforementioned increases in mortality and hospitalization were attributable, at least in part, to the population aging in Korea. As to cardiovascular risk factors, a high proportion of Korean adults were carrying more than one risk factor, and the number of risk factors escalated with older age.
Considering the rapid population aging in Korea, the continued increase in CVD hospitalization and mortality appears inevitable. Moreover, the age-dependent distributions of cardiovascular risk factors imply an even greater burden predicted in the future. Thus, concerted and sustained efforts are crucial among healthcare professionals, policymakers, and the general population themselves to achieve early prevention and subsequently reduce the burden of CVD in Korea.
Footnotes
Funding: This work was supported by the Korean Society of Cardiology (2020).
Conflict of Interest: The authors declare that there is no conflict of interest relevant to this work.
Data Sharing Statement: The data generated in this study is available from the corresponding author(s) upon reasonable request.
- Conceptualization: Cho SMJ, Lee H, Baek J, Bae JH, Chung WJ, Kim HC.
- Data curation: Lee HH, Cho SMJ, Lee H, Baek J, Bae JH.
- Formal analysis: Lee HH, Cho SMJ, Lee H, Baek J, Bae JH.
- Funding acquisition: Chung WJ, Kim HC.
- Investigation: Lee HH, Cho SMJ, Lee H, Baek J.
- Methodology: Lee HH, Lee H, Kim HC.
- Project administration: Lee H, Bae JH, Chung WJ, Kim HC.
- Resources: Kim HC.
- Supervision: Lee H, Chung WJ, Kim HC.
- Validation: Chung WJ.
- Visualization: Cho SMJ, Kim HC.
- Writing - original draft: Lee HH.
- Writing - review & editing: Cho SMJ, Lee H, Baek J, Bae JH, Chung WJ, Kim HC.
SUPPLEMENTARY MATERIALS
Changes in cardiovascular disease mortality rate, 1983–2018
Changes in cardiovascular disease hospitalization rate, 2002–2018
Changes in age-standardized cardiovascular disease hospitalization rate, 2002–2018
Changes in age-standardized cardiovascular disease mortality rate, 1983–2018. (A) In men. (B) In women. Age-standardization was performed by the direct method with the population structure of the resident-registered people in 2018 as a reference, separately for men and women.
Heart Disease Fact Sheet 2020
References
- 1.GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi: 10.1016/S0140-6736(18)32203-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.World Health Organization. Cardiovascular diseases fact sheet [Internet] Geneva: WHO; 2017. [cited 2021 January 7]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) [Google Scholar]
- 3.Statistics Korea. Causes of Death Statistics in 2019. Daejeon: Statistics Korea; 2020. [Google Scholar]
- 4.Mensah GA, Wei GS, Sorlie PD, et al. Decline in cardiovascular mortality: possible causes and implications. Circ Res. 2017;120:366–380. doi: 10.1161/CIRCRESAHA.116.309115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lee SW, Kim HC, Lee HS, Suh I. Thirty-year trends in mortality from cardiovascular diseases in Korea. Korean Circ J. 2015;45:202–209. doi: 10.4070/kcj.2015.45.3.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lee SW, Kim HC, Lee HS, Suh I. Thirty-year trends in mortality from cerebrovascular diseases in Korea. Korean Circ J. 2016;46:507–514. doi: 10.4070/kcj.2016.46.4.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sung KC, Ryu S, Cheong ES, et al. All-cause and cardiovascular mortality among Koreans: effects of obesity and metabolic health. Am J Prev Med. 2015;49:62–71. doi: 10.1016/j.amepre.2015.02.010. [DOI] [PubMed] [Google Scholar]
- 8.Hong JS, Kang HC, Lee SH, Kim J. Long-term trend in the incidence of acute myocardial infarction in Korea: 1997-2007. Korean Circ J. 2009;39:467–476. doi: 10.4070/kcj.2009.39.11.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kim RB, Kim HS, Kang DR, et al. The trend in incidence and case-fatality of hospitalized acute myocardial infarction patients in Korea, 2007 to 2016. J Korean Med Sci. 2019;34:e322. doi: 10.3346/jkms.2019.34.e322. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Seo SR, Kim SY, Lee SY, et al. The incidence of stroke by socioeconomic status, age, sex, and stroke subtype: a nationwide study in Korea. J Prev Med Public Health. 2014;47:104–112. doi: 10.3961/jpmph.2014.47.2.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kim JY, Kang K, Kang J, et al. Executive summary of stroke statistics in Korea 2018: a report from the epidemiology research council of the Korean Stroke Society. J Stroke. 2019;21:42–59. doi: 10.5853/jos.2018.03125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lee JH, Lim NK, Cho MC, Park HY. Epidemiology of heart failure in Korea: present and future. Korean Circ J. 2016;46:658–664. doi: 10.4070/kcj.2016.46.5.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Youn JC, Han S, Ryu KH. Temporal trends of hospitalized patients with heart failure in Korea. Korean Circ J. 2017;47:16–24. doi: 10.4070/kcj.2016.0429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kim HC, Cho SMJ, Lee H, et al. Korea hypertension fact sheet 2020: analysis of nationwide population-based data. Clin Hypertens. 2021;27:8. doi: 10.1186/s40885-021-00166-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kim BY, Won JC, Lee JH, et al. Diabetes fact sheets in Korea, 2018: an appraisal of current status. Diabetes Metab J. 2019;43:487–494. doi: 10.4093/dmj.2019.0067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Park JY, Hong SJ, Joo HJ, et al. Dyslipidemia fact sheets in Korea, 2020 [Internet] Seoul: The Korean Society of Lipid and Atherosclerosis; 2020. [cited 2021 March 9]. Available from: https://www.lipid.or.kr/bbs/skin/default/download.php?code=fact_sheet&number=1392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nam GE, Kim YH, Han K, et al. Obesity fact sheet in Korea, 2018: data focusing on waist circumference and obesity-related comorbidities. J Obes Metab Syndr. 2019;28:236–245. doi: 10.7570/jomes.2019.28.4.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Huh JH, Kang DR, Jang JY, et al. Metabolic syndrome epidemic among Korean adults: Korean survey of cardiometabolic syndrome (2018) Atherosclerosis. 2018;277:47–52. doi: 10.1016/j.atherosclerosis.2018.08.003. [DOI] [PubMed] [Google Scholar]
- 19.Seong SC, Kim YY, Khang YH, et al. Data resource profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46:799–800. doi: 10.1093/ije/dyw253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kweon S, Kim Y, Jang MJ, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES) Int J Epidemiol. 2014;43:69–77. doi: 10.1093/ije/dyt228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Baek J, Lee H, Lee HH, Heo JE, Cho SM, Kim HC. Thirty-six year trends in mortality from diseases of circulatory system in Korea. Korean Circ J. 2021;51:320–332. doi: 10.4070/kcj.2020.0424. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Changes in cardiovascular disease mortality rate, 1983–2018
Changes in cardiovascular disease hospitalization rate, 2002–2018
Changes in age-standardized cardiovascular disease hospitalization rate, 2002–2018
Changes in age-standardized cardiovascular disease mortality rate, 1983–2018. (A) In men. (B) In women. Age-standardization was performed by the direct method with the population structure of the resident-registered people in 2018 as a reference, separately for men and women.
Heart Disease Fact Sheet 2020